Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Mayo Clinic
Baylor College of Medicine
City of Hope Medical Center
Brigham and Women's Hospital
NuCana plc
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cancer Research UK
Zhejiang Provincial People's Hospital
Comprehensive Support Project for Oncology Research
Sun Yat-sen University
Icahn School of Medicine at Mount Sinai
Massachusetts General Hospital
Herlev Hospital
Mayo Clinic
Institut du Cancer de Montpellier - Val d'Aurelle
Ludwig Institute for Cancer Research
Institut Bergonié
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
AHS Cancer Control Alberta
OHSU Knight Cancer Institute
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
NYU Langone Health
Case Comprehensive Cancer Center